Vasospastic Angina and Ca Channel Blockers

ISSN: 1875-6506 (Online)
ISSN: 1573-4021 (Print)


Volume 10, 4 Issues, 2014


Download PDF Flyer




Current Hypertension Reviews

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Prof. Kazuomi Kario
Jichi Medical University
School of Medicine
Tochigi
Japan


View Full Editorial Board

Subscribe Purchase Articles Order Reprints


Vasospastic Angina and Ca Channel Blockers

Author(s): Shinya Minatoguchi

Affiliation: Department of Cardiology, Gifu University Graduate School of Medicine, Gifu, Japan, Yanagido 1-1, Gifu, Gifu 501-1194, Japan.

Abstract

Coronary artery spasm is one of the causes of angina pectoris,acute myocardial infarction and ventricular fibrillation-related sudden death. It has been established that Ca channel blockers are protective against vasospastic angina (VSA) and treatment with Ca channel blockers provides a better prognosis of VSA. However, it is not still clarified what kinds of Ca channel blockers shows the best prognosis of VSA. We performed a meta-analysis in which 4Ca channel blockers amlodipine, nifedipine, benidipine and diltiazem were used for the treatment of VSA patients and found that among 4 Ca channel blockers, benidipine showed a statistically significant better prognostic effect on MACE than amlodipine, nifedipine or diltiazem.

Keywords: Ca channel blocker, cardiovascular event, vasospastic angina.

Purchase Online Rights and Permissions

  
  



Article Details

Volume: 9
Issue Number: 3
First Page: 219
Last Page: 223
Page Count: 5
DOI: 10.2174/1573402110666140131161338
Advertisement

Related Journals



Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science